CFM Wealth Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,000
Closed -$258K 184
2021
Q4
$258K Hold
1,000
0.06% 155
2021
Q3
$289K Hold
1,000
0.07% 148
2021
Q2
$200K Buy
+1,000
New +$194K 0.05% 172
2020
Q4
Sell
-2,905
Closed -$428K 168
2020
Q3
$428K Hold
2,905
0.16% 93
2020
Q2
$359K Hold
2,905
0.14% 101
2020
Q1
$280K Hold
2,905
0.13% 107
2019
Q4
$290K Buy
+2,905
New +$244K 0.11% 118

Other funds holding RGEN

CFM Wealth Partners's RGEN Position: Q1 2022 in Review

CFM Wealth Partners sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,000 shares — an estimated $258K sold.

CFM Wealth Partners first reported a position in RGEN in Q4 2019 and held it in 7 quarters. The position peaked at $428K in Q3 2020. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • CFM Wealth Partners reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • CFM Wealth Partners sold 1,000 Repligen shares in Q1 2022, an estimated $258K.
  • CFM Wealth Partners first reported a position in Repligen in Q4 2019 and held it in 7 quarters.
  • CFM Wealth Partners's Repligen position peaked at $428K in Q3 2020.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on CFM Wealth Partners's 13F filing for Q1 2022, filed 14 Apr 2022.